Facebook
Twitter
LinkedIn
ForwardNCCN Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) offer evidence-based recommendations to support oncologists and other healthcare professionals in making critical clinical decisions. Continuously updated to reflect evolving data, the guidelines provide access to high-quality information evaluated by expert clinicians from NCCN Member Institutions.
While the NCCN Guidelines address appropriate care for about 95% of patients with cancer, individual patient circumstances—such as general health, disease specifics, prior treatments, and patient preferences—must guide their application. Tumor Boards provide a forum for review of multidisciplinary considerations, patient-specific factors, and tumor-specific recommendations that influence effective application of the NCCN Guidelines to ensure that care is tailored to each patient and to optimize management across various cancer types.
Target Audience
This program is designed to meet the educational needs of physicians/oncologists, nurse practitioners, nurses, physician associates, pharmacists, and other health care professionals who manage patients with cancer.
Learning Objectives
The goal of this project is to ensure that members of the interprofessional oncology care team have the knowledge and skills necessary to:
- Apply the current recommendations for oncology care and key updates in the NCCN Guidelines to optimize the management of patients with various cancer types.
- Evaluate new, emerging, and novel therapeutic agents, treatment strategies, and clinical trials data and apply relevant findings into the management of patients with cancer.
- Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with cancer and the delivery of oncology care.
Skin Cancers Except Melanoma - Radiation Therapy Treatment Options
Friday, August 1, 2025 • 11:00 AM – 12:00 PM EDT
Arya Amini, MD, Badri Modi, MD, and Krupal Patel, MD, City of Hope National Medical Center
Exploring De-escalation of Radiation Therapy in the Management of Rectal Cancer
Wednesday, September 17, 2025 • 11:00 AM – 12:00 PM EDT
Tiago Biachi de Castria, MD, PhD; Sarah E. Hoffe, MD; and Seth Felder, MD, Moffitt Cancer Center
WEBINAR TIMES ARE EASTERN DAYLIGHT TIME (EDT) (UTC/GMT -4:00) OR EASTERN STANDARD TIME (EST) (UTC/GMT -5:00).
Access to participate in selected sessions is through Zoom on the day of each scheduled program.
The most recent recorded webcasts from this series will be listed below. Recordings from the previous series can be found here.
NCCN Continuing Education Disclosure Policy
It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates and discloses to learners all relevant financial relationships.
In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing.
Definitions
Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.
Faculty Disclaimers
All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.
Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.
Full disclosure of faculty relationships will be made prior to the activity.
This program has been approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for physician associates, nurses, pharmacists, case managers, and other health care professionals. Complete accreditation information is provided before each individual educational activity.
Price
Required Hardware/software
To complete this activity, users will need:
- A device with an Internet connection and sound playback capability
- One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer is no longer supported
- Adobe Reader or other PDF reader software for certificate viewing/printing